Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SRPT
#1936
Sarepta Therapeutics, Inc. - Common Stock
20.9
7
USD
+0.01%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.53%
Monthly Change
+40.08%
6 month change
+29.36%
Year Change
+16.18%
Previous Close
20.8
6
Open
20.9
2
Low
20.9
2
High
21.1
6
Volume
621
Markets
US Stock Market
Healthcare
Biotechnology
SRPT
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
Q2, 26
Current
Key stats
Total common shares outstanding
98.28 M
97.71 M
104.79 M
104.99 M
105.58 M
105.63 M
105.63 M
Valuation ratios
Enterprise value
7.17 B
2.3 B
2.44 B
2.29 B
2.67 B
2.17 B
2.56 B
Price to earnings ratio
-24.27
-21.11
-6.53
-3.02
-22.67
-6.2
-7.44
Price to sales ratio
2.89
0.71
0.82
0.98
1.08
0.99
1.18
Price to cash flow ratio
-11.21
-5.04
-6.8
-10.49
11.14
13.1
15.73
Price to book ratio
1.3
0.34
0.37
1.89
0.44
0.35
0.42
Enterprise value to EBITDA ratio
-91.62
57.28
-31.79
-3.49
439.02
-13.47
-25.93
Profitability ratios
Return on assets %
-0.13
0.05
-0.05
-0.12
0.1
-0
-0
Return on equity %
-0.39
0.15
-0.14
-0.36
0.22
-0
-0
Return on invested capital %
-63.51
25.05
-17.02
-83.2
70.5
7.12
7.12
Gross margin %
100
100
100
-6.57
100
97.11
97.11
Operating margin %
-40.33
18.91
-25.89
-92.92
49.05
3.31
3.31
EBITDA margin %
-38.99
20.69
-21.27
-91.74
50.5
5.91
5.91
Net margin %
-60.08
32.22
-45.06
-93.07
45.29
-1.22
-1.22
Liquidity ratios
Quick ratio
2.46
1.81
1.79
1.48
2.62
2.62
2.62
Current ratio
4.02
2.89
2.95
2.32
4.63
4.42
4.42
Inventory turnover
—
—
—
—
0
0.01
0.01
Asset turnover
0.2
0.17
0.11
0.13
0.22
0.13
0.13
Solvency ratios
Debt to assets ratio
0.33
0.31
0.3
0.25
0.26
0.27
0.27
Debt to equity ratio
1
0.84
0.78
0.73
0.56
0.55
0.55
Long term debt to total assets ratio
0.33
0.31
0.3
0.25
0.26
0.27
0.27
Long term debt to total equity ratio
1
0.84
0.78
0.73
0.56
0.55
0.55
Per share metrics
Operating cash flow per share
-5.99
2.45
-0.15
1.31
-1.66
1.87
1.37
EBIT per share
-3.09
1.08
-1.03
-4.11
2.94
0.13
-2.08
EBITDA per share
-2.98
1.19
-0.85
-4.06
3.03
0.22
-1.65
Total debt per share
11.69
10.69
10.33
8.28
6.87
8.04
8.04
Cash per share
5.37
7.5
8.49
9.39
5.36
7.48
7.48
Net current asset value per share
24.98
24.92
27.16
25.35
18.95
21.09
21.09
Tangible book value per share
11.74
12.73
12.87
11.1
12.09
14.2
14.2
Working capital per share
18.76
16.29
17.97
14.41
14.85
16.32
16.32
Book value per share
11.74
12.73
13.17
11.39
12.35
14.49
14.49
News
KROS $20M Takeda Milestone Adds Cash but Revenue Visibility Stays Weak
Should You Buy KROS Stock as Pipeline Promise Meets Revenue Risk?
Sarepta's Q2 Earnings & Sales Beat Estimates, '26 Outlook Updated
Sarepta Therapeutics (SRPT) Q2 Earnings and Revenues Surpass Estimates
Compared to Estimates, Sarepta Therapeutics (SRPT) Q2 Earnings: A Look at Key Metrics
ANI Pharmaceuticals (ANIP) Reports Next Week: Wall Street Expects Earnings Growth
ANI Pharmaceuticals (ANIP) Reports Next Week: Wall Street Expects Earnings Growth
Earnings Preview: Sarepta Therapeutics (SRPT) Q2 Earnings Expected to Decline
SRPT Stock Slides 10% in a Week: Is Dyne Therapeutics a Threat?
Dyne Therapeutics Trades Sideways Over An FDA Hurdle. Is It Time To Take Profits?
uniQure Trends to Watch as Gene Therapy Bets Shift Beyond Hemgenix
SRPT or PRTA: Which Is the Better Value Stock Right Now?